Prognostic relevance of PRSS2 and its immune correlates in papillary thyroid carcinoma.

Open Med (Wars) · 2025 · PMC12552859 · PMID 41141930

Europe PMC DOI

hedged sentence

0.0995

closest p · 2.0× alpha

0.0995

boldest claim

The sentences

did not reach statistical significanceP = 0.0995so close (0.05 < p ≤ 0.1)

In Figure 2b , analysis of overall survival stratified by PRSS2 expression levels and clinical stage showed that in stage III patients, high PRSS2 expression correlated with improved survival percent ( P = 0.0353), whereas in stage II, a similar trend was observed but did not reach statistical significance ( P = 0.0995, Figure 2b ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.